The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
NCT ID: NCT06452966
Last Updated: 2024-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
350 participants
INTERVENTIONAL
2024-05-07
2027-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this clinical trial is to learn if traditional Chinese medicine(TCM) is effective for prevention and treatment of organ failure in ICU patients. Patients in this group will receive intervention for 2 weeks.
A multi-center non-randomized real word data study, will include 3 groups: intervention group (TCM)(n=70), control group and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023).
Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Traditional Chinese Medicine for Complications in Critically Ill Patients
NCT05458687
A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients
NCT07136935
Traditional Chinese Medicine for Treatment of Chronic Heart Failure
NCT01939236
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186
Using the Objective Physiological Parameters to Test TCM Syndrome in Sub-health Subjects
NCT04516629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A multi center non-randomized real word data study, will include 3 groups: intervention group (n=70), control group (patients recruited enrolled to the ICU during the study period) and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023). The intervention group will receive traditional Chinese herbal medicine and/or acupuncture and/or low level laser applied on acupuncture points depending on TCM doctor decision and patient TCM diagnosis. Intervention period will be 2 weeks.
Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
patients in the group will recived one of or a combination of the following intervantions:
1. Oral Chinese medicine decoction:
The Chinese medicine practitioner will personally examine the patient and judge the patient's condition through the four diagnostic methods of traditional Chinese medicine(TCM): sight, smell, inquiry, and incision. Based on the syndrome differentiation and treatment of the patient's condition, he or she will prescribe an oral Chinese herbal decoction, two to three times a day, for two weeks.
2. Acupuncture or low level laser acupuncture treatment:
Chinese medicine practitioners select acupuncture points for treatment based on the patient's condition and treat them twice a week for 20 minutes each time for a total of two weeks.
the intervantion depents on the TCM doctor decision based on the patient's diagnosis and needs.
in addition, the patients will recive ICU care and medication based on patient's needs.
traditional Chinese medicine
patients in the group will receive one of or a combination of the following interventions:
Oral Chinese medicine decoction:
The Chinese medicine practitioner will personally examine the patient and judge the patient's condition through the four diagnostic methods of traditional Chinese medicine(TCM): sight, smell, inquiry, and incision. Based on the syndrome differentiation and treatment of the patient's condition, he or she will prescribe an oral Chinese herbal decoction, two to three times a day, for two weeks.
Acupuncture or low level laser acupuncture treatment:
Chinese medicine practitioners select acupuncture points for treatment based on the patient's condition and treat them twice a week for 20 minutes each time for a total of two weeks.
the intervantion depents on the TCM doctor decision based on the patient's diagnosis and needs.
in addition, the patients will recive ICU care and medication based on patient's needs.
control group
the patients in this group will receive routine ICU care. the patients will be recruted during the study period. the patients will not recive TCM intervantions.
Routine ICU care
Patients will receive ICU care
Historical control
Patients admitted to the same ICU in the period of 01.2019 to 12.2023. the patients did not recivied TCM intervantions
historical Routine ICU care
Patients had received ICU care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
traditional Chinese medicine
patients in the group will receive one of or a combination of the following interventions:
Oral Chinese medicine decoction:
The Chinese medicine practitioner will personally examine the patient and judge the patient's condition through the four diagnostic methods of traditional Chinese medicine(TCM): sight, smell, inquiry, and incision. Based on the syndrome differentiation and treatment of the patient's condition, he or she will prescribe an oral Chinese herbal decoction, two to three times a day, for two weeks.
Acupuncture or low level laser acupuncture treatment:
Chinese medicine practitioners select acupuncture points for treatment based on the patient's condition and treat them twice a week for 20 minutes each time for a total of two weeks.
the intervantion depents on the TCM doctor decision based on the patient's diagnosis and needs.
in addition, the patients will recive ICU care and medication based on patient's needs.
Routine ICU care
Patients will receive ICU care
historical Routine ICU care
Patients had received ICU care
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgical ICU patients
* The use of Chinese medicine must be approved by the attending physician in the surgical intensive care unit
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University Hospital
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMUH113-REC3-052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.